Immune checkpoint inhibitors therapy for solid organ malignancies after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT Transplant Complications Working Party

被引:0
作者
Brijs, J. [1 ]
Peczynski, C. [2 ,3 ]
Boreland, W. [2 ,3 ]
Cuoghi, A. [4 ]
Maertens, J. [1 ,5 ]
Mohty, M. [6 ]
Kroeger, N. [7 ]
Nakov, P. [8 ]
Broers, A. E. C. [9 ]
Eder, M. [10 ]
Arroyo, C. Herrera [11 ]
Kaufmann, M. [12 ]
Ram, R. [13 ]
Schaap, N. P. M. [14 ]
Graham, C. [3 ,15 ]
Mussetti, A. [3 ,16 ]
Penack, O. [3 ,17 ]
Moiseev, I. [3 ,18 ]
Peric, Z. [3 ,19 ,20 ]
Schoemans, H. [1 ,3 ,21 ]
机构
[1] Univ Hosp Leuven, Dept Hematol, Leuven, Belgium
[2] Sorbonne Univ, EBMT Paris Study Off, St Antoine Hosp, EBMT Paris Study Off,CEREST TC,INSERM UMR-S 938, Paris, France
[3] INRIA, Paris, France
[4] Univ Modena, Azienda Ospedaliero, Modena, Italy
[5] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Leuven, Belgium
[6] Univ UPMC, Hop St Antoine, INSERM, Paris, France
[7] Univ Med Ctr Hamburg, Dept Stem Cell Transplantat, Hamburg, Germany
[8] Univ Hosp Schleswig, Dept Med 2, Campus Kiel, Holstein Campus Kiel, D-24105 Kiel, Germany
[9] Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands
[10] Hannover Med Sch, Dept Hematol, Hannover, Germany
[11] Hosp Univ Reina Sofia, Cordoba, Spain
[12] Robert Bosch Hosp Stuttgart, Stuttgart, Germany
[13] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Tel Aviv Sourasky Med Ctr,Bone Marrow Transplantat, IL-69978 Tel Aviv, Israel
[14] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
[15] Kings Coll London, Comprehens Canc Ctr, London, England
[16] Inst Invest Biomed Bellvitge IDIBELL, Hosp Duran i Reynals, Catalan Inst Oncol, Dept Hematol, LHospitalet de Llobregat, Barcelona, Spain
[17] Charite Univ Med Berlin, Dept Hematol Oncol & Tumor Immunol, Med Clin, Berlin, Germany
[18] Pavlov First St Petersburg State Med Univ, RM Gorbacheva Res Inst, St Petersburg, Russia
[19] Univ Rijeka, Univ Hosp Ctr Rijeka, Dept Hematol, Rijeka, Croatia
[20] Univ Rijeka, Sch Med, Rijeka, Croatia
[21] KU Leuven Univ Leuven, Dept Publ Hlth Primary Care, ACCENTVV, Leuven, Belgium
关键词
BLOCKADE;
D O I
10.1038/s41409-024-02497-8
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:415 / 417
页数:3
相关论文
共 12 条
  • [1] CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation
    Bashey, Asad
    Medina, Bridget
    Corringham, Sue
    Pasek, Mildred
    Carrier, Ewa
    Vrooman, Linda
    Lowy, Israel
    Solomon, Scott R.
    Morris, Lawrence E.
    Holland, H. Kent
    Mason, James R.
    Alyea, Edwin P.
    Soiffer, Robert J.
    Ball, Edward D.
    [J]. BLOOD, 2009, 113 (07) : 1581 - 1588
  • [2] Blazar BR, 1999, J IMMUNOL, V162, P6368
  • [3] Immune therapy of metastatic melanoma developing after allogeneic bone marrow transplant
    Cecchini, Michael
    Sznol, Mario
    Seropian, Stuart
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2015, 3
  • [4] B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome
    Fridman, Wolf H.
    Meylan, Maxime
    Petitprez, Florent
    Sun, Cheng-Ming
    Italiano, Antoine
    Sautes-Fridman, Catherine
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (07) : 441 - 457
  • [5] PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD
    Haverkos, Bradley M.
    Abbott, Diana
    Hamadani, Mehdi
    Armand, Philippe
    Flowers, Mary E.
    Merryman, Reid
    Kamdar, Manali
    Kanate, Abraham Sebastian
    Saad, Ayman
    Mehta, Amitkumar
    Ganguly, Siddhartha
    Fenske, Timothy S.
    Hari, Parameswaran
    Lowsky, Robert
    Andritsos, Leslie
    Jagasia, Madan
    Bashey, Asad
    Brown, Stacey
    Bachanova, Veronika
    Stephens, Deborah
    Mineishi, Shin
    Nakamura, Ryotaro
    Chen, Yi-Bin
    Blazar, Bruce R.
    Gutman, Jonathan
    Devine, Steven M.
    [J]. BLOOD, 2017, 130 (02) : 221 - 228
  • [6] Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation
    Ijaz, Awais
    Khan, Ali Younas
    Malik, Saad Ullah
    Faridi, Warda
    Fraz, Muhammad Asad
    Usman, Muhammad
    Tariq, Muhammad Junaid
    Durer, Seren
    Durer, Ceren
    Russ, Atlantis
    Parr, Nadia Nunes Cavalcante
    Baig, Zeeshan
    Sagar, F. N. U.
    Ali, Zeeshan
    McBride, Ali
    Anwer, Faiz
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (01) : 94 - 99
  • [7] Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
    Martins, Filipe
    Sofiya, Latifyan
    Sykiotis, Gerasimos P.
    Lamine, Faiza
    Maillard, Michel
    Fraga, Montserrat
    Shabafrouz, Keyvan
    Ribi, Camillo
    Cairoli, Anne
    Guex-Crosier, Yan
    Kuntzer, Thierry
    Michielin, Olivier
    Peters, Solange
    Coukos, Georges
    Spertini, Francois
    Thompson, John A.
    Obeid, Michel
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (09) : 563 - 580
  • [8] Immune checkpoints inhibitors for solid tumours after allogeneic haematopoietic stem-cell transplantation: About four clinical cases
    Monneur, Audrey
    Monnier, Jilliana
    Gaudy-Marqueste, Caroline
    Devillier, Raynier
    Sabatier, Renaud
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 81 : 138 - 141
  • [9] Toxicity associated with PD-1 blockade after allogeneic haematopoietic cell transplantation
    Ortega, Sanchez Guacimara
    Frank, Stenner
    Stefan, Dirnhofer
    Jakob, Passweg
    Sabine, Gerull
    Jorg, Halter P.
    Alfred, Zippelius
    Heinz, Laubli
    [J]. SWISS MEDICAL WEEKLY, 2019, 149
  • [10] Subsequent Cancers in Patients Affected with Moderate or Severe Chronic Graft-versus-Host Disease
    Schaar, Dana A.
    Pirsl, Filip
    Holtzman, Noa
    Steinberg, Seth M.
    Nashed, Jeannette
    Ruben, Claire
    Cowen, Edward W.
    Mays, Jacqueline W.
    Mitchell, Sandra
    Ostojic, Alen
    Munshi, Pashna N.
    Joe, Galen O.
    Comis, Leora E.
    Morton, Lindsay
    Pavletic, Steven Z.
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (11): : 937.e1 - 937.e7